About 18 results found for searched term "OK2" (0.094 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M9414 | OK432 | Cytokines and Growth Factors |
| OK432 is a freeze-dried vaccine. OK432-activated neutrophils can kill IFN-γ or TNF-α-treated cancer cells. | ||
| M15041 | Recombinant Human MEC/CCL28 (E. coli) | Cytokines and Growth Factors |
| Chemokine (C-C motif) ligand 28; CCL-28; SCYA28 | ||
| CCL28 (CC chemokine ligand 28), a novel CC chemokine, was identified by TBLASTN search using the human Genome System (HGS) and Genbank dbEst databases using a consistent sequence of human chemokines. Protein structure: CCL28 (Ser20-Tyr127), Accession # ：Q9NRJ3. | ||
| M15016 | Recombinant Human Eotaxin-2/CCL24 (E. coli) | Cytokines and Growth Factors |
| C-C motif chemokine 24; CK-beta-6 | ||
| Recombinant human Eotaxin-2/CCL24 protein (E. coli) is a new CC chemokine recently discovered. It is produced by activated monocytes and T lymphocytes. Protein structure: CCL24 (VAL27-ALA104), Accession # : O00175. | ||
| M15053 | Recombinant Mouse CCL2/MCP-1 (E.coli) | Cytokines and Growth Factors |
| C-C motif chemokine 2; Monocyte chemoattractant protein 1 | ||
| Recombinant mouse C-C Motif Chemokine 2, produced by escherichia coli expression system, expressed the target gene encoding GLN24-ARG96. Accession # : P10148. | ||
| M21346 | Recombinant Human Cuteaneous T-cell Attracting Chemokine/CCL27 (E.coli ) | Cytokines and Growth Factors |
| AA Sequence：FLLPPSTACC TQLYRKPLSD KLLRKVIQVE LQEADGDCHL QAFVLHLAQR SICIHPQNPS LSQWFEHQER KLHGTLPKLN FGMLRKMG.Accession: Q9Y4X3. | ||
| M40811 | Recombinant Mouse CCL21 Protein (E. coli) | Cytokines and Growth Factors |
| C-C Motif Chemokine 21a | ||
| C-C Motif Chemokine 21a (CCL21) is a small secreted cytokine that belongs to the intercrine beta (CC chemokine) family. Mouse CCL21 inhibits hemopoiesis and stimulates chemotaxis. It has chemotactic function in vitro for thymocytes and activated T-cells, but not for B-cells, macrophages, or neutrophils. | ||
| M42079 | OK2 | EGFR/HER2 |
| OK2, a specific inhibitor of the CCN2/EGFR interaction, efficiently blocks CCN2/EGFR interaction through binding to the CT domain of CCN2. | ||
| M43964 | Cholecystokinin (26-33), CCK8 TFA | Cholecystokinin Receptor |
| Cholecystokinin Octapeptide, desulfated TFA; CCK Octapeptide, desulfated TFA | ||
| Cholecystokinin (26-33), CCK8 TFA is a synthetic desulfated octapeptide cholecystokinin (CCK). Sequence: Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | ||
| M51100 | Cholecystokinin (1-21) | Others |
| Cholecystokinin (1-21) (CCK-1-21) is a cholecystokinin (CCK) fragment. | ||
| M51415 | Cholecystokinin Octapeptide (1-2) (desulfated) | Others |
| Cholecystokinin Octapeptide (1-2) (desulfated) (H-Asp-Tyr-OH) is a polypeptide that can be found by peptide screening. | ||
| M51454 | [Thr28, Nle31]-Cholecystokinin (25-33), sulfated | Others |
| [Thr28, Nle31]-Cholecystokinin (25-33) is a biological active peptide. | ||
| M52612 | Prokineticin 2 Isoform 2 (human) | Metabolite/Endogenous Metabolite |
| Prokineticin 2 Isoform 2 (human) is a hypothalamic neuropeptide. | ||
| M54114 | Cholecystokinin (26-33) (free acid) | Others |
| Cholecystokinin (26-33) (CCK (26-33)) free acid is a cholecystokinin (CCK) fragment. | ||
| M57769 | p62-ZzligandYOK-2204 | Others |
| p62-ZzligandYOK-2204 | ||
| M57927 | YOK-2204linkerconjugate1 | Others |
| YOK-2204linkerconjugate1 | ||
| M58382 | Recombinant Human HK2 Protein (Baculovirus-Insect, C-His) | Cytokines and Growth Factors |
| Hexokinase 2; HKII Protein | ||
| Hexokinase 2 (HK2) is a rate-determining enzyme in aerobic glycolysis, a process upregulated in tumor cells. HK2 expression is controlled by various transcription factors and epigenetic alterations and is heterogeneous in hepatocellular carcinomas (HCCs). | ||
| M58383 | Recombinant Human HK2 Protein (E. coli, N-His) | Cytokines and Growth Factors |
| Hexokinase 2; HKII Protein | ||
| Hexokinase 2 (HK2) is a rate-determining enzyme in aerobic glycolysis, a process upregulated in tumor cells. HK2 expression is controlled by various transcription factors and epigenetic alterations and is heterogeneous in hepatocellular carcinomas (HCCs). | ||
| M58530 | Benitrobenrazide | Others |
| Hexokinase 2 inhibitor 1 | ||
| Benitrobenrazide (Hexokinase 2 inhibitor 1) is a hexokinase 2 (HK2) inhibitor with anticancer and antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
